相关实验视频
Updated: May 23, 2025
11:19
Robotic Myotomy and Partial Fundoplication for Achalasia
Published on: August 11, 2023
1.4K
皮洛里克功能障碍:对机制,诊断和治疗的审查
Hee Kyong Na1,2, Andrew A Li2, Andres Gottfried-Blackmore3
1Department of Gastroenterology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Gut and liver
|March 9, 2025
概括
胃腺功能障碍是一种影响胃空化的疾病,涉及到胃腺关节的高血压或. 胃外口内镜性胆髓瘤术显示出作为耐火性胃衰竭的最少侵入性治疗方法的前景.
科学领域:
- 胃肠病学 胃肠病学
- 消化系统生理学 消化系统生理学
背景情况:
- 螺柱体功能障碍,以螺柱体关节高血压或为特征,影响胃排空.
- 胆柱在胃空化的确切作用尚未完全理解.
- 有限的研究存在于胃衰竭中的胆囊功能障碍,诊断和治疗方法不成熟.
研究的目的:
- 为了审查胆囊功能障碍的病理生理学.
- 探索用于胆囊功能评估的新兴诊断方式.
- 总结目前和新的治疗干预措施,以治疗甲状腺功能障碍.
主要方法:
- 关于 recent pyloric 功能障碍的最近研究的文献综述.
- 评估先进的诊断技术,如高分辨率的两门膜测量和内膜功能光成像.
- 治疗选择的分析,包括药理学药物,肉毒素注射,内扩张,支架,手术性脊柱造形术和胃口内透镜脊柱造形术.
主要成果:
- 高分辨率 antroduodenal manometry 和 endoluminal 功能光线成像正在评估用于诊断pyloric 功能.
- 针对 pylorus 的各种治疗方法已经提出,从药物治疗到手术干预.
- 胃外口内镜性胆髓瘤切除被确定为一种新的,最小侵入性疗法,具有已证明的耐火性胃衰竭的有效性和安全性.
结论:
- 骨功能障碍在理解和管理胃衰竭方面是一个重大挑战.
- 新的诊断工具正在出现,以更好地评估胆道功能.
- 胃口内腔内镜胆髓瘤术在治疗耐火性胃衰竭方面取得了重大进展.
相关概念视频
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
75
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
75
01:30Peptic Ulcer Disease I: Introduction
114
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
114
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
333
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
333
01:26Peptic Ulcer Disease IV: Management
57
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
57
01:22Pathophysiology of Peptic Ulcer Disease: Injurious Factors
513
Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
513
01:28Peptic Ulcer Disease II: Pathophysiology
198
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
198